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Abstract Optical coherence tomography is a new tech-
nology that provides an atraumatic “optical biopsy” provid-
ing both anatomical and possible histopathologic results. It
has only recently been incorporated into the urological
Weld. This paper highlights previous and prospective
advances of optical coherence tomography in urology and
its potential application in robotic urologic surgery.
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Introduction
The search for atraumatic evaluation of tissue during sur-
gery has led to the development of optical coherence
tomography (OCT). An “optical biopsy” is a non-invasive
method of providing anatomical and potentially histologi-
cal evaluation through imaging.
Optical coherence tomography is an FDA-approved por-
table imaging system (Figs. 1 and 2) that provides real time
histologic imaging. The system is analogous to ultrasound,
however uses infrared light rather than acoustical waves
and, unlike ultrasound, does not require direct contact with
tissue or a transducing medium. The infra-red light is back-
scattered from the patient’s tissue, collected by the probe’s
Wber, and, combined with a reference signal, produces a
high spatial resolution image of the tissue microstructure. It
acquires real-time images with 200 £ 200 pixels, 15-m
depth resolution in free space (11 m in tissue), and 25 m
lateral resolution. Given that OCT is Wber-optic based, it
allows for easy integration with endoscopes and catheters.
Optical coherence tomography was Wrst applied in oph-
thalmology where it was used initially for transparent tis-
sues of the eye. Since then, OCT has expanded its role to
include macular disease, retinal pathology and corneal
abnormalities [1, 2]. Once OCT established itself in imag-
ing delicate tissue, further expansion of its armamentarium
to include solid organs was justiWed. Through technological
modiWcations, “optical biopsies” of organs including gas-
trointestinal, cardiovascular, respiratory, skin, nervous sys-
tem, and male and female reproductive organs have been
performed [3–7].
The Wrst application of optical coherence tomography in
urology occurred in 1997 when in-vitro imaging of bladder,
prostate, ureteral biopsies and neurovascular bundles were
compared to H and E staining. As the Wrst comparative
study, high-resolution cross-sectional imaging obtained
from OCT correlated well with the histological architecture
of all the tissues sampled [8].
In this review, we highlight current and future applica-
tions of optical coherence tomography in the Weld of urology.
Methods
Through a comprehensive computer-based Medline search,
MESH terms including optical coherence tomography and/
or laparoscopy, robotic, surgery, urology, bladder, prostate,
cancer, and endoscopy were applied. All papers relevant to
the use of optical coherence tomography in urological prac-
tice and published in English were included, such as case
reports, and prospective, retrospective, and randomized
studies. Basic science and animal research were also incor-
porated with, again, strict relevance to urological use.
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A total of 18 journal articles evaluating optical coherence
tomography and urology were evaluated. Nine papers were
in relation to optical coherence tomography and urothelial
abnormalities. The remaining journals focus primarily in
OCT’s role in the imaging characteristics of the prostate or
prostate cancer. There is currently a solitary paper evaluat-
ing the use of optical coherence tomography in robotic
urological practice.
Bladder
Urothelial malignancies are detected more commonly at a
superWcial stage and, although not aggressive, pose a sig-
niWcant challenge in monitoring due to high recurrence
rates. Early detection and treatment of non-muscle invasive
bladder cancer is paramount for bladder preservation and
longevity. Cystoscopy is considered the gold standard in
the diagnosis and surveillance of urothelial carcinoma.
However, diagnostic cystoscopy may overlook unapparent
tumors, or falsely interpret malignant lesions as benign.
Secondly, cystoscopy does not provide information on sub-
mucosal architecture to determine depth of tumor penetra-
tion once a lesion is identiWed.
An imaging modality that can provide near histopathol-
ogical information can be an important diagnostic and
prognostic tool for treating urothelial carcinoma. Jessner
et al. [9] compared in-vitro OCT images to H and E analy-
sis of human bladder tumor resection fragments. The
tomography of muscle invasive urothelial carcinoma
demonstrated architectural re-arrangement of the muco-
sal, submucosal, and muscularis boundaries in addition to
individual muscle bundles. Manyak et al. [10] was able to
address the in-vitro limitation of this study by imaging the
urothelium in vivo. Twenty-four patients that were visu-
ally suspected of having urothelial carcinoma were
scanned using OCT. Tomography was able to detect 29 of
the 36 suspect areas in addition to discriminating between
lamina propria and muscularis propria invasion. Overall,
OCT proved to be 100% sensitive and 89% speciWc with a
negative predictive value of 100%. Although preliminary,
OCT provides additional pathological information during
diagnostic cystoscopy for the detection and staging of
urothelial carcinoma.
Apart from malignancy, there are occasions where
benign processes of the bladder are mistaken for malig-
nancy. Unfortunately, these cases are diagnosed following
a series of invasive bladder biopsies. Optical coherence
tomography has demonstrated its ability to not only discern
normal from malignant change, but also diVerentiate
between proliferative and non-proliferative lesions of the
bladder [11]. A few examples of optical coherence tomog-
raphy of the bladder demonstrating carcinoma in situ are
seen in Figs. 3a, b.
Fig. 1 Niris computer-based 
system with a laparoscopic 
probe
Fig. 2 Niris probe in vivo during animal robotic prostate surgery.
Note the Xexible OCT probe placed on the endopelvic fascia using the
robotic articulating graspers123
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Prostate cancer has become the leading cancer diagnosed in
men today. Although there are various modes of treatment
of prostate cancer, radical prostatectomy has been shown to
improve survival beyond 15 years [12]. Despite its overall
survival advantage, radical prostatectomy carries inherent
risks of incontinence and erectile dysfunction. Although
anatomical nerve-sparing radical prostatectomy [13] has
had a signiWcant impact on postoperative potency, the over-
all outcomes do not meet both patient and surgeon expecta-
tions. During nerve-sparing radical prostatectomy,
anatomical location of the neurovascular bundles is inferred
on the basis of the vascular supply of the prostate. There is
currently no established visual modality available to con-
clusively identify the neurovascular bundles during radical
prostatectomy. However, Boppart et al. [14] has shown that
optical coherence tomography can provide real-time in-
vitro imaging during prostate surgery. Figures 4a and 4b
depict tomographical images of the prostate.
There are currently four methods of performing radical
prostatectomy—the perineal, retropubic, laparoscopic, and
robot-assisted techniques. With the expanded role of OCT,
the potential use of in-vivo imaging of the neurovascular
bundles during radical prostatectomy is now real. At our
institution, the Wrst FDA-approved OCT imaging system
for non-ophthalmologic use, Niris (Imalux, Cleveland, OH,
USA) was used in vivo clinically [15]. The Niris system
was applied to 24 patients that underwent either laparo-
scopic or robot-assisted radical prostatectomy. The eight
French Niris probes can be inserted into the laparoscopic
ports during surgery. Optical coherence tomography appli-
cation during the procedure did not add to the operative
time or morbidity to the patient. In an attempt to evaluate
the feasibility of nerve-sparing prostatectomy, specimens
were examined both in vivo and in vitro for the presence or
absence of the neurovascular bundles. Optical coherence
tomography was performed during the radical prostatec-
tomy in an attempt to preserve the nerves using real-time
data acquisition. Over 300 images using OCT were accu-
mulated including those of the endopelvic fascia, fat,
lymphatics, prostatic capsule, and neurovascular bundles.
In four patients who underwent a wide excision of the
Fig. 3 a Optical coherence tomography of the bladder urothelium
demonstrating carcinoma in situ. No clear urothelial layer is identiWed
and the combined urothelium and lamina propria are bright. b Optical
coherence tomography of the carcinoma in situ. Preserved horizontal
layering indicates no invasion into the muscularis propria
Fig. 4 a Surface tomography of the prostate demonstrating a dense
Wbromuscular stroma. b Surface tomography of the prostate showing a
complex subcapsular venous network123
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proved a 100% correlation between the OCT image and the
histological examination of the prostate. Figures 5a and 5b
demonstrate the characteristic images of the neurovascular
bundles along the prostate.
More recently, Fried et al. [16] has used OCT’s properties
to identify the cavernousal nerves via an open rodent model.
Six male Sprague–Dawley rats were anaesthetized and
underwent open surgical exploration of the cavernous and
ipsilateral major pelvic ganglion. Following identiWcation of
the neurovascular structures, simultaneous cavernousal nerve
stimulation and intracavernousal pressure monitoring was
performed. This approach provided conWrmation of the
neurovascular bundle detected by OCT. A typical response
achieved during 30 s of nerve stimulation resulted in a pres-
sure increase from 10 to 80 mmHg. Following stimulation,
these animals were euthanized to evaluate the OCT image
in comparison to the histological appearance of the neuro-
vascular bundle.
Examining the real-time optical coherence tomography
during nerve-sparing radical prostatectomy will be the
next logical step. By identifying the nerves prospectively
with OCT, perhaps an improved functional outcome can
result.
Kidney
It has been well established that partial nephrectomy has
equivalent oncological results to radical nephrectomy in
select patients [17]. The technique of performing partial
nephrectomy can include laparoscopic or open approaches.
The minimally invasive approach is technically demanding
due to surgical resection and reconstruction of the kidney,
usually within a limited time of warm ischemia. Optical
coherence tomography and its use in laparoscopic partial
nephrectomy have been explored at our institution. Chung
et al. [18] incorporated the Niris system in eleven laparo-
scopic partial nephrectomies. Over 500 images were
obtained during the surgical extirpation of the renal mass.
Images of the parenchyma and the capsule both on and
adjacent to the renal mass were obtained. Optical coherence
tomography was able to detect structural abnormalities
adjacent to and on the capsule of nine histologically con-
Wrmed renal cell carcinomas (Figs. 6a, b).
Limitations and challenges
A limitation of OCT is its shallow depth of penetration and
image acquisition. Limited by its probe size and diameter,
multiple data sites and angles are required to obtain an
impression of the anatomical structure being observed. Fur-
ther experience with OCT in conjunction with histological
analysis will also aid the operator in discerning from vari-
ous structures which demonstrate overlapping imaging
characteristics. For example, lymphatic tissue looks very
similar tomographically to neural tissue (Fig. 7).
Conclusion
The prospective beneWt of optical coherence tomography
is promising for operative urology. Although relatively
Fig. 5 a Optical coherence tomography of the neurovascular bundle
along the prostate. b Cross-sectional tomography of a neurovascular
bundle along the prostatic capsule123
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to evolve. With further technological advances in robotic
surgery, a synergy between imaging and surgery will
provide improved operative results and reduced patient
morbidity.
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